Showing results (51-60 of 105) with videos related to

Sort By:
Pageof 11
Proceedings of the National Academy of Sciences of the United States of America|January 31, 2009
Quantitative peptidomics reveal brain peptide signatures of behaviorAxel Brockmann, Suresh P Annangudi, Timothy A Richmond, et al.
Molecular Psychiatry|April 16, 2025
A single-cell genomic atlas for the effects of chronic ethanol exposure in the mouse dorsal striatumErin Wildermuth, Michael S Patton, Marcia Cortes-Gutierrez, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 3, 2023
Transcriptomic profiling of reward and sensory brain areas in perinatal fentanyl exposed juvenile miceJimmy Olusakin, Gautam Kumar, Mahashweta Basu, et al.
Plos One|January 6, 2007
Transcriptional changes common to human cocaine, cannabis and phencyclidine abuseElin Lehrmann, Carlo Colantuoni, Amy Deep-Soboslay, et al.
Pathogens (Basel, Switzerland)|December 16, 2020
Putative Autoantigen Leiomodin-1 Is Expressed in the Human Brain and in the Membrane Fraction of Newly Formed NeuronsDavid W Nauen, Michael C Haffner, Juyun Kim, et al.
American Journal of Human Genetics|February 7, 2012
DNA methylation signatures in development and aging of the human prefrontal cortexShusuke Numata, Tianzhang Ye, Thomas M Hyde, et al.
Neuroscience Research|October 15, 2013
Olfactory cells via nasal biopsy reflect the developing brain in gene expression profiles: utility and limitation of the surrogate tissues in research for brain disordersYasue Horiuchi, Shin-Ichi Kano, Koko Ishizuka, et al.
Biological Psychiatry|November 26, 2022
Adaptations in Nucleus Accumbens Neuron Subtypes Mediate Negative Affective Behaviors in Fentanyl AbstinenceMegan E Fox, Andreas B Wulff, Daniela Franco, et al.
Disease Models & Mechanisms|April 10, 2025
Altered huntingtin-chromatin interactions predict transcriptional and epigenetic changes in Huntington's diseaseJocelynn R Pearl, Amol C Shetty, Jeffrey P Cantle, et al.
Frontiers in Neurology|June 23, 2022
Peptidylarginine Deiminase 2 Autoantibodies Are Linked to Less Severe Disease in Multiple Sclerosis and Post-treatment Lyme DiseaseYaewon Kim, Alison W Rebman, Tory P Johnson, et al.
Pageof 11